← 治験一覧に戻る
ガドブトロル・マグネビスト対照ボディスタディ
基本情報
- NCT ID
- NCT01050829
- ステータス
- 完了
- 試験のフェーズ
- 第3相
- 試験タイプ
- 介入
- 目標被験者数
- 370
- 治験依頼者名
- Bayer
概要
The purpose of the study is to look at the safety (what are the side effects) and efficacy (how well does it work) of gadobutrol when used for taking MR images of the body/extremities regions. The results of the MRI with gadobutrol injection will be compared to the results of MR images taken without contrast and with the results of the MR images taken with Magnevist.
対象疾患
Magnetic Resonance Imaging
介入
Gadobutrol (Gadovist, BAY86-4875)(DRUG)
Gadopentetate Dimeglumine (Magnevist, BAY86-4882)(DRUG)
依頼者（Sponsor）
バイエル薬品株式会社(INDUSTRY)